Display options
Cite
Danelli L, Frossi B, Pucillo CE. Mast cell/MDSC a liaison immunosuppressive for tumor microenvironment. Oncoimmunology. 2015;4(4):e1001232doi: 10.1080/2162402X.2014.1001232.
Danelli, L., Frossi, B., & Pucillo, C. E. (2015). Mast cell/MDSC a liaison immunosuppressive for tumor microenvironment. Oncoimmunology, 4(4), e1001232. https://doi.org/10.1080/2162402X.2014.1001232
Danelli, Luca, et al. "Mast cell/MDSC a liaison immunosuppressive for tumor microenvironment." Oncoimmunology vol. 4,4 (2015): e1001232. doi: https://doi.org/10.1080/2162402X.2014.1001232
Danelli L, Frossi B, Pucillo CE. Mast cell/MDSC a liaison immunosuppressive for tumor microenvironment. Oncoimmunology. 2015 Mar 24;4(4):e1001232. doi: 10.1080/2162402X.2014.1001232. eCollection 2015 Apr. PMID: 26137400; PMCID: PMC4485753.
Copy Download .nbib Format: NLM
Share it on

Oncoimmunology. 2015 Mar 24;4(4):e1001232. doi: 10.1080/2162402X.2014.1001232. eCollection 2015 Apr.

Mast cell/MDSC a liaison immunosuppressive for tumor microenvironment.

Oncoimmunology

Luca Danelli, Barbara Frossi, Carlo E Pucillo

Affiliations

  1. Department of Medical and Biological Science; University of Udine ; Udine, Italy ; Inserm UMRS-1149; CNRS ERL 8252; Laboratoire d'excellence INFLAMEX; Université Paris Diderot; Sorbonne Paris Cite ; Paris, France.
  2. Department of Medical and Biological Science; University of Udine ; Udine, Italy.

PMID: 26137400 PMCID: PMC4485753 DOI: 10.1080/2162402X.2014.1001232

Abstract

The instauration of an immunosuppressive microenvironment is a key event in cancer development and progression. Here, we discuss increasing evidences of the crosstalk between myeloid-derived suppressor cells (MDSCs) and mast cells (MCs) as a new fuel for the cancer immunosuppressive machinery.

Keywords: CD40:CD40L; colon carcinoma; immunosuppression; mast cells; myeloid derived suppressor cells

References

  1. Cancer Res. 2011 Mar 1;71(5):1627-36 - PubMed
  2. J Leukoc Biol. 2014 Apr;95(4):643-50 - PubMed
  3. Blood. 2008 Aug 15;112(4):1269-79 - PubMed
  4. Cancer Metastasis Rev. 2011 Jun;30(2):177-84 - PubMed
  5. PLoS One. 2010 Jan 27;5(1):e8922 - PubMed
  6. Cancer Immunol Res. 2015 Jan;3(1):85-95 - PubMed
  7. Blood. 2008 Apr 15;111(8):4233-44 - PubMed
  8. J Immunol. 2012 Jul 15;189(2):511-5 - PubMed
  9. Cell Rep. 2012 Sep 27;2(3):628-39 - PubMed

Publication Types